Board summary
Key figures
45,304
Registered population
63.5% aged 18–64
15.8%
Aged 65+
ICB 18.8% · England 17.9%
23.0%
Ethnic minority (non-White)
14.5% Asian · England 9.6%
4.0%
In IMD quintile 1
ICB 0.8% · England 21.0%
~1,954
Core20 residents (est.)
Resident basis; registered basis ~1,872 · see page 3
6,398
Hypertension register
+4.79% in 3 yrs · England +5.60%
370
SMI register
41.6% of Spelthorne's
634
COPD register
Reviews +7.60% in 3 yrs
Forecast to 2030
7,728
Hypertension patients, 2030
+1,330 on today
70.5%
QRISK ≥20% on statins, 2030
+3.60pp over 3 yrs
4.1%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Core20 deprivation concentrated at St David's Family Practice.
St David's Family Practice holds a 12.3% Core20 share (1,872 estimated patients), against 0.0% at Stanwell Road Surgery, Hythe Medical Centre Surgery and Staines.
Hypertension control and primary prevention statins trail England.
Despite 88.4% BP recording, hypertension control is 65.4% (England 70.3%; 60.6% in under-80s) and non-CVD diabetes statin prescribing is 66.4% (England 73.2%).
COPD annual reviews and infant 6-in-1 outperform England.
COPD annual reviews reach 88.8% (England 76.4%, up 7.6% over 2023 to 2025) and 24-month 6-in-1 immunisation reaches 96.6% (above the 95.0% target).
Population, age and ethnicity
A younger population (15.8% aged 65+) pairs with a 23.0% ethnic minority share
Across 45,304 registered patients, 15.8% are aged 65+, below Spelthorne (17.4%), the ICB (18.8%), and England (17.9%). Working-age adults (18–64) comprise 63.5% and children (0–17) 20.7%. Census resident data, reflecting catchment geography rather than registered patients, indicates a 23.0% ethnic minority share, led by Asian residents at 14.5% (Spelthorne 12.8%, ICB 7.7%, England 9.6%), rising to 24.0% at St David's Family Practice. An unverified ONS projection estimates 7.8% list growth by 2030 (Spelthorne 5.6%, ICB 4.9%, England 2.3%), though its methodology is unverified.
Age profile
65+: ICB 18.8%, England 17.9%
Ethnicity
Older people · falls rows are Spelthorne local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Spelthorne LA) | 1,875 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.6% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 55.1% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Spelthorne LA) | 950 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Spelthorne LA) | 10.7 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation reaches 4.0% across the PCN but sits entirely within one practice
The PCN Core20 cohort is 4.0%, above Spelthorne (1.8%) and the ICB (0.8%) but below England (21.0%). Deprivation is highly concentrated: St David's Family Practice has a 12.3% Core20 share (1,872 estimated patients), while Stanwell Road Surgery, Hythe Medical Centre Surgery and Staines Health Group each record 0.0%. A 0.11 percentage point reconciliation difference separates the 4.1% weighted practice share from the 4.0% PCN rate. Associated small areas contain an estimated 1,954 Core20 residents across age bands.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
370
SMI register
0.80% recorded prevalence
165
Learning disability register
0.36% recorded prevalence
11
Care homes, 362 beds
In the PCN catchment
8.6%
Provide unpaid care
Spelthorne, Census 2021
Registers include 370 patients with severe mental illness (0.8%) and 165 with learning disabilities (0.4%), alongside 11 catchment care homes with 362 beds. Separate Spelthorne figures show an 8.6% unpaid care rate and 3 rough sleepers in 2025, which cannot be directly extrapolated to practice lists. Recorded learning disability prevalence matches Spelthorne (0.4%) but sits below England (0.6%), which may reflect a younger population rather than under-detection, pending clinical audits.
Severe mental illness: physical health checks
Recorded SMI checks trail England: blood pressure checks reached 76.8% (75.4% at St David's Family Practice; England 83.4%), BMI reached 75.2% (69.7% at St David's Family Practice; England 82.1%), and alcohol recording reached 74.2% (England 81.8%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,398
Hypertension register
+4.79%
Register growth, 3 yrs
Spelthorne +4.33% · England +5.60%
−0.25pp
BP control, under 80
≤140/90 · −0.53pp aged 80+
+1,330
More patients by 2030
Forecast 7,728 (15.25%)
Hypertension case-finding and control
Recorded hypertension prevalence is 13.9% (6,398 patients), below Spelthorne (15.7%), the ICB (14.3%) and England (15.2%), though unadjusted rates do not confirm under-detection. While 88.4% had a recent blood pressure check (England 90.0%), treatment to target reaches 65.4% against 69.5% in Spelthorne, 71.4% in the ICB and 70.3% in England. For patients aged under 80, control to <= 140/90 mmHg is 60.6% (fell 0.4% over 2023 to 2025; England +3.2%), trailing Spelthorne (64.7%) and England (67.8%), and reaching 58.7% at St David's Family Practice. Blood pressure control trails comparators across the PCN, indicating hypertensive adults under 80 could benefit from prioritised medication titration.
Lipids and statins
Statin treatment for diabetic patients without cardiovascular disease is 66.4%, below Spelthorne (69.5%) and England (73.2%), while secondary prevention reaches 84.2% (England 84.4%). QRISK >= 20% coverage is 62.6% (England 63.6%). Primary prevention statin uptake trails comparators, indicating diabetic adults without cardiovascular disease could be prioritised for therapy review.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 59,769 | £1.70 | £2.24 | £1.86 | £101,607 |
| Cardiovascular (all), 2025 | 81,753 | £3.71 | £4.74 | £3.33 | £303,304 |
In 2026, 59,769 lipid-modifying items cost £1.70 each, below England (£1.86) and NHS Surrey Heartlands Integrated Care Board (£2.24). The PCN spent £9,563 less than England's unit cost and £32,275 less than the ICB's across these items.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+6.26%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+4.20%
Asthma prevalence, PCN 3-yr % change
The PCN asthma register records 2,238 patients (5.2% prevalence vs 6.6% England). Annual reviews reached 69.7% (England 65.7%), leaving an estimated 678 patients without a recorded review. Asthma management prescribing for ages 5–19 is 954 items per 1,000 (England 1,488). The COPD register holds 634 patients (1.4% prevalence vs 1.9% England) and fell 2.2% over 2023 to 2025 (England +2.6%), while annual reviews reached 88.8% (England 76.4%).
Cancer register and children's immunisation
The cancer register records 1,575 patients (3.4% prevalence vs 3.8% England). In childhood immunisations, 24-month 6-in-1 coverage reaches 96.6%, exceeding the 95.0% target by 1.6 pp. At age 5, 4-in-1 booster coverage is 80.5% (below the 95.0% target by 14.5 pp) and MMR dose 2 is 85.0% (below the 95.0% target by 10 pp), with a 6.7 pp gap from dose 1 (14.3 pp at Hythe Medical Centre Surgery).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
61.4%
Surrey Heartlands ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~650
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Surrey Heartlands ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 65.7% | 53.2% | 18% | 1,044 |
| Breast | 88.2% | 85.4% | 27% | 798 |
| Bowel | 48.1% | 47.0% | 18% | 626 |
| Lung | 33.2% | 33.8% | 17% | 497 |
| Skin cancer | 89.8% | 87.8% | 19% | 384 |
Across NHS Surrey Heartlands ICB, 61.4% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (2,955 of 4,810), exceeding England (55.3%) but sitting 13.6 pp below the 75.0% national ambition by 2028, representing about 650 additional early-stage diagnoses required annually. Known-stage completeness was 67.7% (4,810 of 7,106; England 67.0%). System data reflects the wider health economy rather than PCN delivery. Locally, PCN cervical screening coverage in women aged 25-49 is 61.6% (below England 66.8% and ICB 69.3%) after falling 8.1% (England -1.0%) over 2023 to 2025. Trailing screening uptake may delay cancer identification across the network, making targeted recall clinically urgent.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026, Ashford and St Peter's Hospitals NHS Foundation Trust met the cancer 62-day standard on 76.4% of pathways (against the 85.0% standard), below The Hillingdon Hospitals NHS Foundation Trust (84.0%) and Frimley Health NHS Foundation Trust (81.8%), but above NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). Faster diagnosis reached 85.5% (standard 75.0%) and 31-day treatment was 94.2% (standard 96.0%). Across all diagnostic tests, 23.1% of patients waited 6+ weeks, higher than The Hillingdon Hospitals (11.0%) and Frimley Health (7.5%), matching England (23.1%). Provider performance reflects acute trusts rather than PCN delivery.
| Pathways within standard (%) | Ashford and St Peter's | Hillingdon | Frimley Health | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 85.53 | 79.63 | 87.95 | 79.29 | 79.32 |
| 31-day treatment (96%) | 94.21 | 96.67 | 92.89 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 76.38 | 84.05 | 81.84 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Ashford and St Peter's | Hillingdon | Frimley Health | England |
|---|---|---|---|---|
| MRI | 0.09 | 3.99 | 12.85 | 21.40 |
| CT | 9.27 | 3.21 | 0.63 | 9.92 |
| Echocardiography | 0.97 | 0.92 | 3.35 | 28.48 |
| Colonoscopy | 49.61 | 26.58 | 22.84 | 30.83 |
| Gastroscopy | 56.74 | 26.56 | 7.43 | 29.02 |
| All 15 DM01 tests | 23.12 | 10.98 | 7.49 | 23.14 |
| Community services activity | Surrey residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 109,530 | 309,615 |
| Referrals | 28,700 | 66,930 |
| Patients with a contact | 33,510 | 85,660 |
Community services (residents of Surrey), Jun 2026 (provisional). In provisional June 2026 Community Services Dataset records, 69.6% of community contacts with Spelthorne borough residents (76,215 of 109,530) were with adults aged 65 and over. These borough-level resident figures describe wider community activity rather than exclusive PCN delivery, highlighting that community service demand is heavily oriented toward older residents across the local authority.
Practice variation and patient experience
Practice phone access spans 29.7 pp, while vaccination achievement ranges from 40.7% to 68.7%
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Hythe | 94 | 0.0 | 61.3% | 81.9% | 78.1% |
| St David's | 108 | 12.3 | 62.8% | 67.8% | 76.7% |
| Staines Health | 83 | 0.0 | 33.1% | 70.9% | 64.3% |
| Stanwell Road | 112 | 0.0 | 37.4% | 69.2% | 63.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Heart failure reviews fell 1.6% while 15 of 25 measures trail England
Over 2023 to 2025, 15 of 25 measures trailed England's three-year change. Heart failure reviews fell 1.6% (England +8.7%), despite current reach of 79.5% (England 78.5%), and learning disability prevalence fell 4.3% (England +5.4%). Conversely, COPD reviews grew 7.6% (England +2.8%) to 88.8% (England 76.4%). Non-frail diabetes HbA1c control improved 11.5% (England +4.4%), though its 55.1% level trails the ICB at 59.5%. Prioritising recall audits across declining review pathways may recover ground before clinical control erodes.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Learning disability register
Cervical screening
Breast screening (53-70)
COPD register
Diabetes HbA1c control
Alcohol record (psychosis)
COPD reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Spelthorne | Asset | PCN | Spelthorne |
|---|---|---|---|---|---|
| Care homes (catchment) | 11 (362 beds) | n/a | Schools (catchment) | 45 | n/a |
| Children's centres | 4 | 6 | Places of worship | 39 | 43 |
| Libraries | 1 | 1 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | n/a | 1 | Carers support groups (VCS) | n/a | 1 |
| Primary schools (LA maintained) | 7 | 8 | Primary academies | 5 | 8 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Hypertension titration and case-finding audit
Among 6,398 hypertension patients (13.9% vs 15.7% Spelthorne, 15.2% England; unadjusted gap +502 to +695), BP control is 65.4% (England 70.3%) and 60.6% under 80 (58.7% at St David's Family Practice). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
Standardised asthma annual review recall
On the 2,238-patient asthma register (5.2% prevalence vs 5.6% Spelthorne, 6.6% England), 69.7% had a recorded annual review (Spelthorne 70.6%, England 65.7%), leaving an estimated 678 patients unreviewed. For discussion, practices could run a standardised recall template alongside after-school or flexible review slots and inhaler prescribing checks. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 3
COPD case-finding and register audit
Recorded COPD prevalence is 1.4% (634 patients vs 1.5% Spelthorne, 1.9% England) and fell 2.2% over 2023 to 2025 (England +2.6%), giving an unadjusted benchmark gap of +59 to +224 patients. Moderate effort to run.
Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.
Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Tailored ethnic minority outreach (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Targeted Core20 outreach and engagement (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical health checks (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension titration review (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school immunisation recall (p6) | 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Telephony and access review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Hypertension titration and case-finding audit (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP reading | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
| Option 2 · Standardised asthma annual review recall (p12) | Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN & Practice |
| Option 3 · COPD case-finding and register audit (p12) | COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 months | Core20PLUS5 approach · Tobacco and Vapes Bill | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
